Unicycive

Unicycive Therapeutics enables nephrologists to meet their patients' medical needs effectively.

Launch date

2016

Employees

Market cap

Net debt

-

Enterprise valuation

$16m (Public information from Jun 2024)

Los Altos California (HQ)

http://unicycive.com

https://twitter.com/unicycive https://www.linkedin.com/company/unicycive/

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	0000	0000	0000	0000	0000	0000	0000
% growth	-	-	-	(29 %)	394 %	632 %	918 %
EBITDA	0000	0000	0000	0000	0000	0000	0000
% EBITDA margin	-	-	(1898 %)	(2944 %)	-	-	-
Profit	0000	0000	0000	0000	0000	0000	0000
% profit margin	-	-	(1899 %)	(4525 %)	(774 %)	(116 %)	42 %
EV / revenue	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
EV / EBITDA	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
R&D budget	0000	0000	0000	0000	0000	0000	0000
R&D % of revenue	-	-	1308 %	1911 %	-	-	-

Get premium to view all results

Date	Investors	Amount	Round
Mar 2019	N/A	$0.0	round
Jul 2021	N/A	$0.0	round
Mar 2023	investor investor investor	$0.0	round
Apr 2024*	N/A	$50.0m	Post IPO Equity
Total Funding		000k